Evidence map›Paper›PMID 28193625›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics.

Mandy L Y Sin, Kathleen E Mach, Rahul Sinha, Fan Wu, Dharati R Trivedi, Emanuela Altobelli, Kristin C Jensen, Debashis Sahoo, Ying Lu, Joseph C Liao

Abstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers-What Should a Urologist Really Know?International journal of environmental research and public health · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mandy L Y SinDepartment of Urology, Stanford University School of Medicine, Stanford, California.
Kathleen E MachDepartment of Urology, Stanford University School of Medicine, Stanford, California.
Rahul SinhaInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.
Fan WuVeterans Affairs Palo Alto Health Care System, Palo Alto, California.
Dharati R TrivediDepartment of Urology, Stanford University School of Medicine, Stanford, California.
Emanuela AltobelliDepartment of Urology, Stanford University School of Medicine, Stanford, California.
Kristin C JensenVeterans Affairs Palo Alto Health Care System, Palo Alto, California.
Debashis SahooDepartments of Pediatrics and Computer Science and Engineering, University of California San Diego, San Diego, California.
Ying LuVeterans Affairs Palo Alto Health Care System, Palo Alto, California.
Joseph C LiaoDepartment of Urology, Stanford University School of Medicine, Stanford, California. jliao@stanford.edu.

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Optical Imaging of Bladder Cancer with Molecular Contrast AgentsR01CA160986 · NCI · STANFORD UNIVERSITY · PI LIAO, JOSEPH C · 2011 to 2014
$1.7M
Application of Boolean Networks to discover stem and progenitor cellsR00CA151673 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SAHOO, DEBASHIS · 2014 to 2016
$717k
NCI NIH HHS P30 CA124435NCI NIH HHS R00 CA151673NCI NIH HHS R01 CA160986
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

High-Throughput Nucleotide SequencingAdultAgedAged, 80 and overBiomarkers, TumorCystoscopyFemaleGene Expression Regulation, NeoplasticHumansMaleMiddle AgedNeoplasm Recurrence, LocalPathology, MolecularRNAUrinary Bladder NeoplasmsBiomarkers, TumorRNA

Identifiers

PMID28193625
PMCPMC5873297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.